GPCR/G protein - cannabinoid receptor - Serotonin (5-HT) reuptake - Androgen Receptors - Melatonin Receptors
All GPCRs share a common seven trans-membrane structure. GPCRs are associated with heterotrimeric G-proteins which are GTP-binding proteins made of alpha, beta, and gamma subunits. When a ligand binds to GPCR, it activates the attached G-protein, the GDP is replaced with GTP. The activated G-protein then dissociates into an alpha and a beta-gamma complex which activates downstream signaling pathways. These intracellular signaling pathways include cAMP/PKA, calcium/NFAT, phospholipase C, protein tyrosine kinases, MAP kinases, PI-3-kinase, nitric oxide/cGMP, Rho, and JAK/STAT.
GPCRs are one of the most important therapeutic targets for various diseases, over 30% of all modern medicinal drugs target this family. Aberrant GPCR functions are involved in pathological conditions such as neurological, immunological and hormonal disorders. A large number of GPCRs have been identified, but whose ligands are not known, are classified as orphan receptors.
- B6274 N-AcetyltryptamineTarget: Melatonin ReceptorsSummary: 褪黑激素受体调节剂
- B1326 DL-Adrenaline中文名: DL-肾上腺素Target: Androgen ReceptorsSummary: 肾上腺素能受体激动剂
- B1428 GW842166XTarget: cannabinoid receptorSummary: 大麻素受体激动剂
- A1748 Ramelteon1 Citation中文名: 雷美替胺Target: Melatonin ReceptorsSummary: MT1/MT2激动剂
- A2436 Fluoxetine HCl中文名: 盐酸氟西汀Target: Serotonin (5-HT) reuptakeSummary: 5-羟色胺重吸收抑制剂